ReportWire

Tag: The U.S. Supreme Court

  • Supreme Court Accidentally Leaks Its Opinion Apparently Overturning Idaho Emergency Abortion Ban

    Supreme Court Accidentally Leaks Its Opinion Apparently Overturning Idaho Emergency Abortion Ban

    [ad_1]

    The U.S. Supreme Court Wednesday accidentally leaked its opinion in a case involving Idaho’s emergency abortion ban and it appears that the justices will be ruling against the state.

    In the drafted opinion on Moyle V. United States which appeared briefly on the high court’s website and was subsequently removed, the majority of justices sided with the decision to dismiss the case as “improvidently granted” or on the grounds that the court should not have taken it. They did not specify why.

    This determination would reinstate a lower court’s prior ruling that allowed hospitals in Idaho to perform emergency abortions despite the state’s near-total ban on the medical procedure. Per the opinion released on Wednesday, conservative justices Clarence Thomas, Samuel Alito and Neil Gorsuch voted against dismissing the case.

    According to reports, a spokeswoman for the court confirmed that the opinion was published before the final decision. Pending its final release, it could be subject to change. There are two more opinion days in this Supreme Court term.

    This is not the first mishap of its kind. A draft of the decision to overturn Roe v. Wade—which reversed the constitutional right to an abortion—was leaked to the media in May 2022.

    The nation’s highest court heard oral arguments in late April in the case involving Idaho’s abortion ban that challenges whether a federal law that enforces emergency stabilizing care, including abortions, overrides the state mandate that only permits these procedures if, without them, a person would die.

    At the core of the challenge brought forth by the Biden Administration is the Emergency Medical Treatment and Labor Act. First passed in 1986, EMTALA requires all hospitals enrolled in Medicare to provide stabilizing care to patients having a medical emergency.

    If these facilities fail to abide by this requirement, they risk losing the ability to participate in Medicare and other state health programs and could have their provider agreements terminated.

    Idaho Solicitor General Joshua Turner argued that the state was within its jurisdiction to decide how to practice medicine and that each emergent situation would be evaluated and handled on a case-by-case basis.

    Sotomayor and Kagan challenged Turner’s assertions, questioning what would occur in a series of hypothetical patient cases they presented to Turner. Justice Brett Kavanaugh and Thomas appeared to favor siding with Turner’s arguments in tandem with their conservative counterparts.

    Justice Amy Coney Barrett — who has notably been a voice in opposition to abortion — seemed to contradict her usual stance in her line of questioning to Turner. Barrett challenged why the high-risk examples were not exempted under Idaho’s ban if they posed the possibility of death.

    Sotomayor took issue with Turner’s point that there was no objective standard to determining what to do in each situation, only a subjective one based on the physician’s good-faith decision. U.S. Solicitor General Elizabeth Prelogar argued that the case was not about Idaho’s overall ban but the state’s ability to criminalize essential care.

    Hospitals serve primary and maternity care providers for many, especially those living in the growing number of maternal healthcare deserts across the nation. Texas residents, in particular, face this barrier to care, with roughly 50 percent of the state’s 254 counties classified as maternal health deserts without OB-GYNS or birthing facilities as of last year.

    The decision of the nation’s highest court could affect a similar case brought forth by Texas Attorney General Ken Paxton against the BIdne Administration, which is currently pending in the courts. Paxton initiated the lawsuit, challenging the federal government’s ability to require hospitals to offer emergency abortions.

    Most recently, the U.S. Fifth Circuit Court of Appeals sided with Texas. If the ruling is challenged and goes to the U.S. Supreme Court, it will likely be heard in October 2025.

    The final opinion on the Idaho case could come out Thursday or Friday. If the court upholds its decision from the version released on Wednesday, the matter is expected to return to lower courts.

    [ad_2]

    Faith Bugenhagen

    Source link

  • U.S Supreme Court Rejects Challenge to Abortion Pill, Allows it to Stay on the Market

    U.S Supreme Court Rejects Challenge to Abortion Pill, Allows it to Stay on the Market

    [ad_1]

    On Thursday, the U.S Supreme Court rejected a challenge to restricting access to the abortion drug, Mifepristone, effectively shutting down a plea by a group of physicians with anti-abortion views to block circulation of the widely-used pill.

    The court ruled unanimously that medical professionals from the Alliance for Hippocratic Medicine — the lead plaintiff in the case — did not have legal standing to request the reversal of the U.S. Food and Drug Administration’s long-standing approval of the drug or call for additional restrictions on its usage.

    The decision will keep the medication available in states where abortion is legal. Notably, per Texas’s near-total ban on abortion, it will not be available in state Texas to residents.

    Mifepristone will remain accessible via telehealth services, can continue to be distributed by mail and it will not be illegal to take the two-step regimen — misoprostol is the accompanying drug — after the seventh week of pregnancy. The regulated usage protocol will stay the same.

    However, the case will be sent back to the district court, and litigation is likely to continue. U.S. District Judge Matthew J. Kacsmaryk initially ruled to revoke the FDA’s approval of Mifepristone and place additional restrictions on the pill.

    “They are sending this decision back to the lower courts,” Dr. Bhavik Kumar, medical director of primary and trans care at Planned Parenthood Gulf Coast, said. “So, it remains unknown exactly what that means and what that outcome will be.”

    Kumar referred to Thursday’s decision as a “frustrating win.” He said medical professionals, abortion advocates and legal experts have known from the start of this case that the plaintiffs had no legal standing.

    According to Kumar, the group of physicians were able to “cherry-pick” their way through the lower courts to get the matter before the country’s highest court, “We shouldn’t even be here right now,” he said.

    Legal experts questioned what the decision could also mean for other medications on the market. Protect Our Care, a health care advocacy group, noted that the choice could have thrown the entire U.S. drug approval process into chaos.

    Amy O’Donnell, communications director with Texas Alliance For Life, said the pro-life organization expected Thursday’s ruling after the justices discussed legal standing during a March hearing.

    Despite not being surprised by it, O’Donnell noted that it was disappointing and put the health, lives and future fertility of women and girls in the country at risk.

    “This is not the end of the conversation. There are other avenues for us to seek a reversal of those lax guidelines,” O’Donnell said. “We — the pro-life community — can petition to the executive branch. We can seek other ways to go about what the physicians and organizations, in this case, were trying to achieve.”

    O’Donnell and other pro-life advocates take issue with what they refer to as an increased risk of complications linked to medical abortions compared to those associated with surgical abortions.

    Medical professionals often reject this claim and cite the FDA’s 24-year-old approval of Mifepristone.

    “It has been proven safe and effective,” Kumar said. “Over 5 million people have used it, and medical abortions account for 63 percent of all abortions in the United States.”

    Although some in the reproductive rights community view Thursday’s decision as a small reprieve from the ongoing attacks on reproductive health care, many are awaiting the highest court’s next ruling on a case out of Idaho.

    The case challenges whether a federal law — the Emergency Medical Treatment and Active Labor — that requires emergency stabilizing care, including abortions, overrides Idaho state mandate that only permits these procedures if, without them, a person could die.

    Justices heard oral arguments in the case in late April, and a ruling on the matter is pending.

    [ad_2]

    Faith Bugenhagen

    Source link